# Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia.

> **NCT05197686** · NA · UNKNOWN · sponsor: **Pomeranian Medical University Szczecin** · enrollment: 100 (estimated)

## Conditions studied

- Corona Virus Infection
- ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
- Oxygen Deficiency

## Interventions

- **DEVICE:** Oxygen theraphy with high flow nasal cannule
- **DEVICE:** Oxygen theraphy with mask with reservoir

## Key facts

- **NCT ID:** NCT05197686
- **Lead sponsor:** Pomeranian Medical University Szczecin
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-18
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05197686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05197686, "Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05197686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*